KABP–AB-cx13 for the alleviation of airway inflammation in a mouse model triggered by particulate matter 10(PM10) and diesel exhaust particles

KABP-AB-cx 13 suppressed the PM₁₀D-induced airway inflammation and protected lung tissue from damage by inhibiting immune and inflammatory reactions in airways, activating the immune system, and increasing SCFA levels in the gut. KABP-AB-cx 13 also exhibited an expectorant effect, suggesting protective and therapeutic effects against respiratory inflammation. Overall, these findings contribute to global understanding of how probiotic interventions may help prevent or alleviate respiratory disorders induced by air pollution.